Portfolio Lab

Horizon Kinetics Medical ETF

  • ETF
  • Ticker MEDX
  • NASDAQ

Performance, volatility and drawdowns of Horizon Kinetics Medical ETF since 01/2023, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

MEDXGlobal equities (VT)

$10,000 grew to $13,531. Global equities (VT): $15,235.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −23.1% in 04/2025, measured from the peak in 08/2024. It took 13 months to get back to the old peak.

Annual returns

Best year 2025 at +28.6%, weakest 2024 at −4.7%. 1 of 2 full years were positive. * partial year.

Similar ETFs

Frequently asked questions

How has MEDX performed since 01/2023?

$10,000 grew to $12,414 by 20 Nov 2026, which is +5.9% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is MEDX?

Volatility was 15.2% per year, measured on monthly returns. The largest decline from a peak was −23.1%, with the low in 04/2025.

How does MEDX compare with a broad equity ETF?

Over the same period Global equities (VT) returned +13.9% per year at 12.8% volatility, MEDX returned +5.9% at 15.2%. The correlation of monthly returns was 0.47; 1 would mean they moved in lockstep.

What does MEDX hold?

MEDX holds 31 positions. The largest are Eli Lilly & Co, AbbVie Inc and Novartis AG; the 10 largest together make up 67.1% of the fund (holdings as of 30 Jun 2026, according to the fund's filing with the SEC).

Which currency are the figures in?

In US dollars, the currency of the US listing.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Horizon Kinetics Medical ETF (MEDX): Return and risk